Enter your email address
Submit
Write your message
Volume 17, Issue 3 (Iranian Journal of Breast Diseases 2024)
ijbd 2024, 17(3): 95-110 |
Back to browse issues page
Research code: 140205314428
Ethics code: IR.UMSHA.REC.1402.414
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Owliaee P, jenabi E, Rahbar S. An Update: Association between air travel and risk of lymphedema for breast cancer patients: A systematic review and meta-analysis. ijbd 2024; 17 (3) :95-110
URL: http://ijbd.ir/article-1-1087-en.html
URL: http://ijbd.ir/article-1-1087-en.html
1- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
2- Mother and Child Care Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
2- Mother and Child Care Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (557 Views)
Introduction: Lymphedema (LE) is a common complication following breast cancer (BC) treatment, characterized by lymphatic fluid accumulation in the interstitial tissue. The impact of air travel on LE risk in BC patients remains unclear. This study aimed to determine the potential role of air travel in increasing LE likelihood through a systematic review and meta-analysis.
Methods: A comprehensive search was conducted in international databases, including PubMed, Scopus, Science Direct, and Web of Science, until May 2023. The Newcastle-Ottawa Scale was used for quality assessment. A random effects model was applied for meta-analysis, with effect size estimated using odds ratios (OR) and 95% confidence intervals (CI).
Results: Among 3,480 BC patients from 8 studies, the pooled estimates showed no significant association between air travel and LE risk (OR=1.04, 95% CI=0.73 to 1.35). Significant heterogeneity was observed among studies (I2=74.8%, P=0.000).
Conclusion: The results demonstrate that air travel is not a significant risk factor for LE in patients treated for BC. These findings help alleviate concerns about air travel among BC survivors and improve their quality of life.
Methods: A comprehensive search was conducted in international databases, including PubMed, Scopus, Science Direct, and Web of Science, until May 2023. The Newcastle-Ottawa Scale was used for quality assessment. A random effects model was applied for meta-analysis, with effect size estimated using odds ratios (OR) and 95% confidence intervals (CI).
Results: Among 3,480 BC patients from 8 studies, the pooled estimates showed no significant association between air travel and LE risk (OR=1.04, 95% CI=0.73 to 1.35). Significant heterogeneity was observed among studies (I2=74.8%, P=0.000).
Conclusion: The results demonstrate that air travel is not a significant risk factor for LE in patients treated for BC. These findings help alleviate concerns about air travel among BC survivors and improve their quality of life.
Type of Study: review |
Subject:
prevention
Received: 2023/12/21 | Accepted: 2024/08/14 | Published: 2024/10/6
Received: 2023/12/21 | Accepted: 2024/08/14 | Published: 2024/10/6
References
1. Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies- An Updated Review. 2021:1-30.
2. Iacorossi L, Gambalunga F, Molinaro S, De Domenico R, Giannarelli D, Fabi A. The Effectiveness of the Sport "Dragon Boat Racing" in Reducing the Risk of Lymphedema Incidence: An Observational Study. Cancer Nurs. 2019;42(4):323-31. [DOI:10.1097/NCC.0000000000000615]
3. fei Liu Y, Liu JE, Mak YW, Zhu Y, Qiu H, hui Liu L, et al. Prevalence and predictors of breast cancer-related arm lymphedema over a 10-year period in postoperative breast cancer patients: A cross-sectional study. European Journal of Oncology Nursing. 2021;51. [DOI:10.1016/j.ejon.2021.101909]
4. Zhang Y, Li N, Chen J, Luo X, Li M, Yan J. Breast Cancer-Related Lymphedema Risk-Management Behaviors Among Chinese Breast Cancer Survivors and Relationships with Socio-Demographic and Clinical Characteristics: A Longitudinal Study. Patient Preference and Adherence. 2022;16:797-808. [DOI:10.2147/PPA.S356750]
5. Shahpar H, Atieh A, Maryam A, Fatemeh HS, Massoome N, Mandana E, et al. Risk Factors of Lymph Edema in Breast Cancer Patients. International Journal of Breast Cancer. 2013;2013:1-7. [DOI:10.1155/2013/641818]
6. Roberts SA, Gillespie TC, Shui AM, Brunelle CL, Daniell KM, Locascio JJ, et al. Weight loss does not decrease risk of breast cancer-related arm lymphedema. Cancer. 2021;127(21):3939-45. [DOI:10.1002/cncr.33819]
7. Harris SR. Axillary Web Syndrome in Breast Cancer: A Prevalent But Under-Recognized Postoperative Complication. Breast care (Basel, Switzerland). 2018;13(2):132-5. [DOI:10.1159/000485023]
8. Null M, Arbor TC, Agarwal M. Anatomy, Lymphatic System. 2023.
9. Togawa K, Ma H, Smith AW, Neuhouser ML, George SM, Baumgartner KB, et al. Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors. Sci Rep. 2021;11(1):10701. [DOI:10.1038/s41598-021-89055-0]
10. Omar MTA, Gwada RFM, Omar GSM, El-Sabagh RM, Mersal AAE. Low-Intensity Resistance Training and Compression Garment in the Management of Breast Cancer-Related Lymphedema: Single-Blinded Randomized Controlled Trial. J Cancer Educ. 2020;35(6):1101-10. [DOI:10.1007/s13187-019-01564-9]
11. Rebegea L, Firescu D, Dumitru M, Anghel R. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Chirurgia (Bucharest, Romania : 1990). 2015;110(1):33-7.
12. Yeager DS, Hanselman P, Walton GM, Murray JS, Crosnoe R, Muller C, et al. A national experiment reveals where a growth mindset improves achievement. Nature. 2019;573(7774):364-9. [DOI:10.1038/s41586-019-1466-y]
13. Coriddi M, Khansa I, Stephens J, Miller M, Boehmler J, Tiwari P. Analysis of factors contributing to severity of breast cancer-related lymphedema. Annals of Plastic Surgery. 2015;74(1):22-5. [DOI:10.1097/SAP.0b013e31828d7285]
14. Gençay Can A, Ekşioğlu E, Çakçı FA. Early Detection and Treatment of Subclinical Lymphedema in Patients with Breast Cancer. Lymphat Res Biol. 2019;17(3):368-73. [DOI:10.1089/lrb.2018.0033]
15. Gass J, Dupree B, Pruthi S, Radford D, Wapnir I, Antoszewska R, et al. Breast Cancer Survivorship: Why, What and When? Annals of Surgical Oncology. 2016;23(10):3162-7. [DOI:10.1245/s10434-016-5403-0]
16. Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, et al. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res. 2014;16(4):414. [DOI:10.1186/s13058-014-0414-x]
17. Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH, et al. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective. Annals of surgery. 2021;274(1):170-8. [DOI:10.1097/SLA.0000000000003491]
18. Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2005;2(1):47-62. [DOI:10.1111/j.1742-4801.2005.00066.x]
19. Patel KM, Lin CY, Cheng MH. A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer. Ann Surg Oncol. 2015;22(7):2424-30. [DOI:10.1245/s10434-014-4276-3]
20. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surgical Oncology. 2006;15(3):153-65.
https://doi.org/10.1016/j.suronc.2011.06.007 [DOI:10.1016/j.suronc.2006.11.003]
21. Koelmeyer LA, Gaitatzis K, Dietrich MS, Shah CS, Boyages J, McLaughlin SA, et al. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer. 2022;128(18):3408-15. [DOI:10.1002/cncr.34377]
22. fei Liu Y, Liu JE, Zhu Y, Mak YW, Qiu H, hui Liu L, et al. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors. Supportive Care in Cancer. 2021;29(9):5435-45. [DOI:10.1007/s00520-021-06122-y]
23. Leray H, Malloizel-Delaunay J, Lusque A, Chantalat E, Bouglon L, Chollet C, et al. Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. 2020;18(6):510-6. [DOI:10.1089/lrb.2019.0009]
24. Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D. The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. American journal of clinical oncology. 2015;38(2):184-8. [DOI:10.1097/COC.0b013e31828aadc9]
25. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. The Lancet Oncology. 2013;14(6):500-15. [DOI:10.1016/S1470-2045(13)70076-7]
26. Asdourian MS, Skolny MN, Brunelle C, Seward CE, Salama L, Taghian AG. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. The Lancet Oncology. 2016;17(9):e392-e405-e392-e405. [DOI:10.1016/S1470-2045(16)30204-2]
27. Committee NLNMA. Position Statement of the National Lymphedema Network: Risk Reduction. National Lymphedema Network. 2012:1-8.
28. Mittermayr M, Fries D, Innerhofer P, Schobersberger B, Klingler A, Partsch H, et al. Formation of Edema and Fluid Shifts during a Long-haul Flight. Journal of Travel Medicine. 2003;10(6):334-9. [DOI:10.2310/7060.2003.9359]
29. Casley-Smith JR, Casley-Smith JR. Lymphedema initiated by aircraft flights. Aviation, space, and environmental medicine. 1996;67(1):52-6.
30. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71-n. [DOI:10.1136/bmj.n71]
31. Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Research and Treatment. 2005;89(3):221-6. [DOI:10.1007/s10549-004-2045-x]
32. Swenson KK, Nissen MJ, Leach JW, Post-White J. Case-control study to evaluate predictors of lymphedema after breast cancer surgery. Oncology Nursing Forum. 2009;36(2):185-93. [DOI:10.1188/09.ONF.185-193]
33. Mak SS, Lee YM, Tse SM, Ho FP, Chan E, Yeo W, Zee B. Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer. Hong Kong Medical Journal. 2009;15(3 SUPP4):8-12.
34. Showalter SL, Brown JC, Cheville AL, Fisher CS, Sataloff D, Schmitz KH. Lifestyle risk factors associated with arm swelling among women with breast cancer. Annals of Surgical Oncology. 2013;20(3):842-9. [DOI:10.1245/s10434-012-2631-9]
35. Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. Journal of Clinical Oncology. 2016;34(7):691-8. [DOI:10.1200/JCO.2015.61.5948]
36. Asdourian MS, Swaroop MN, Sayegh HE, Brunelle CL, Mina AI, Zheng H, et al. Association Between precautionary behaviors and breast cancer-related lymphedema in patients undergoing bilateral surgery. Journal of Clinical Oncology. 2017;35(35):3934-41. [DOI:10.1200/JCO.2017.73.7494]
37. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GKD, Scott-Conner C. Lymphedema following breast cancer: The importance of surgical methods and obesity. Front Womens Health. 2018;3(2):6.
https://doi.org/10.15761/IOD.1000144 [DOI:10.15761/FWH.1000144]
38. Li F, Lu Q, Jin S, Zhao Q, Qin X, Jin S, Zhang L. A scoring system for predicting the risk of breast cancer-related lymphedema. International Journal of Nursing Sciences. 2020;7(1):21-8. [DOI:10.1016/j.ijnss.2019.12.007]
39. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute2021.
40. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21(11):1539-58. [DOI:10.1002/sim.1186]
41. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997;315(7109):629-34. [DOI:10.1136/bmj.315.7109.629]
42. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101. [DOI:10.2307/2533446]
43. Tatayeva R, Ossadchaya E, Sarkulova S, Sembayeva Z, Koigeldinova S. Psychosomatic Aspects of The Development of Comorbid Pathology: A Review. Medical Journal of the Islamic Republic Of Iran. 2022;36(1):1160-8. [DOI:10.47176/mjiri.36.152]
44. Paterick TE, Patel N, Tajik AJ, Chandrasekaran K. Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent). 2017;30(1):112-3. [DOI:10.1080/08998280.2017.11929552]
45. Fava GA, Cosci F, Sonino N, Guidi J. Understanding Health Attitudes and Behavior. The American journal of medicine. 2023;136(3):252-9. [DOI:10.1016/j.amjmed.2022.10.019]
46. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions2009. [DOI:10.1002/9780470712184]
47. Co M, Ng J, Kwong A. Air Travel and Postoperative Lymphedema-A Systematic Review. Clin Breast Cancer. 2018;18(1):e151-e5. [DOI:10.1016/j.clbc.2017.10.011]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
